Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPA-15406 (difamilast) in mild/moderate atopic dermatitis
NCT02068352Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of difamilast in atopic dermatitis (AD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jun 2014; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02068352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068352.